| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2023 | KIDS Orthopediatrics Corp | Odle Gregory A76 | Executive Vice President | Sell | 80 | $47.00 | $3,760.00 | -0.1% | +5.2% | -38.6% | |
| Jan 20, 2023 | DXCM Dexcom Inc | Sayer Kevin R62 | President CEO And Chairman Of | Sell | 45,607 | $105.75 | $4,822,871.84 | -9.7% | +13.3% | +18.0% | |
| Jan 20, 2023 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 7,638 | $65.17 | $497,790.62 | -0.9% | +22.9% | +27.7% | |
| Jan 20, 2023 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 6,858 | $65.19 | $447,080.18 | -72.5% | +22.9% | +27.7% | |
| Jan 19, 2023 | CTKB Cytek Biosciences, Inc. | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $11.03 | $220,600.00 | -0.3% | -11.5% | -24.9% | |
| Jan 19, 2023 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 374 | $22.93 | $8,575.82 | -0.8% | -17.1% | -28.1% | |
| Jan 19, 2023 | BLFS Biolife Solutions Inc | De Greef Roderick74 | Director | Sell | 3,801 | $23.19 | $88,145.19 | -8.6% | -17.1% | -28.1% | |
| Jan 19, 2023 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 3,538 | $24.72 | $87,456.34 | -3.8% | -17.1% | -28.1% | |
| Jan 19, 2023 | ATEC Alphatec Holdings, Inc. | Miles Patrick53 | CEO | Sell | 180,000 | $13.23 | $2,380,800.00 | -1.1% | +21.8% | +14.8% | |
| Jan 18, 2023 | TMCI Treace Medical Concepts, Inc. | Timbie Thomas E69 | Director | Sell | 50,000 | $25.88 | $1,294,000.00 | -3.8% | -1.5% | -50.7% | |
| Jan 18, 2023 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 6,500 | $25.04 | $162,760.00 | -5.2% | -17.9% | -29.0% | |
| Jan 18, 2023 | AHCO Adapthealth Corp. | Everest Hill Group Inc.86 | 10% Owner | Sell | 4,789 | $22.00 | $105,358.00 | - | -45.8% | -68.5% | |
| Jan 18, 2023 | XTNT Xtant Medical Holdings, Inc. | Neils Scott C | Chief Financial Officer | Sell | 8,673 | $0.61 | $5,282.72 | -2.1% | +5.7% | +84.1% | |
| Jan 18, 2023 | WRBY Warby Parker Inc. | Durable Capital Partners LP56 | 10% Owner | Sell | 8,226 | $16.74 | $137,681.40 | - | -32.9% | -18.4% | |
| Jan 18, 2023 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 1,948 | $16.09 | $31,336.24 | -0.3% | +30.4% | +20.5% | |
| Jan 17, 2023 | SIBN Si-Bone, Inc. | Pisetsky Michael A68 | SVP, Ops &Adm/ Chief Legal Ofr | Sell | 399 | $16.18 | $6,456.66 | -0.2% | +30.0% | +16.9% | |
| Jan 17, 2023 | BRKR Bruker Corp | Friend Cynthia M | Director | Sell | 921 | $68.26 | $62,867.46 | -7.4% | +21.4% | +2.4% | |
| Jan 17, 2023 | TMDX Transmedics Group, Inc. | Carey John F | VP Of Operations | Sell | 1,410 | $62.71 | $88,424.52 | -1.9% | +8.0% | +22.0% | |
| Jan 17, 2023 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 1,739 | $16.14 | $28,073.55 | -1.7% | +30.0% | +16.9% | |
| Jan 17, 2023 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Tmtt | Sell | 4,000 | $78.00 | $312,000.00 | -17.5% | +6.6% | -6.4% | |
| Jan 17, 2023 | BAX Baxter International Inc | Mason Jeanne K69 | SVP, Human Resources | Sell | 59,477 | $44.70 | $2,658,621.90 | -32.0% | -4.0% | -13.5% | |
| Jan 17, 2023 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Sell | 2,912 | $6.31 | $18,374.72 | - | -64.8% | -51.4% | |
| Jan 17, 2023 | MYO Myomo, Inc. | Henry David A72 | Chief Financial Officer | Buy | 76,923 | $0.33 | $24,999.98 | +88.8% | +64.6% | +831.6% | |
| Jan 17, 2023 | MYO Myomo, Inc. | Gudonis Paul R67 | Chief Executive Officer | Buy | 307,692 | $0.33 | $99,999.90 | +175.2% | +64.6% | +831.6% | |
| Jan 17, 2023 | RMD Resmed Inc | Douglas Robert Andrew71 | President And COO | Sell | 1,500 | $220.43 | $330,645.00 | -0.7% | +0.0% | -24.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.